Tiziana Life Sciences Ltd (TLSA)

Price & Market Data

Price: $1.52

Daily Change: +$0.06 / 3.95%

Daily Range: $1.41 - $1.71

Market Cap: $188,343,504

Daily Volume: 576,478

Performance Metrics

1 Week: 9.22%

1 Month: 24.19%

3 Months: 12.41%

6 Months: -3.14%

1 Year: 6.21%

YTD: 2.67%

About Tiziana Life Sciences Ltd (TLSA)

Detailed report on Tiziana Life Sciences Ltd (TLSA). Current price: 1.52, daily change: +$0.06 / 3.95%. Market cap: 188,343,504. Explore all performance metrics.

Company Details

Employees: 10

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United Kingdom

Details

Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.

Selected stocks

Versus Systems Inc. (VS)

Kaltura, Inc. (KLTR)

CBAK Energy Technology, Inc. (CBAT)

Mega Matrix Inc. (MPU)

Full House Resorts, Inc. (FLL)